(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's ...

Novo Nordisk A/S growth is driven by global obesity drug demand, robust pipeline development and manufacturing scale. Read ...

Eli Lilly and Novo Nordisk have agreed to sell their weight loss drugs, Wegovy and Zepbound, through the new TrumpRx ...

Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

WeightWatchers intends to offer Novo Nordisk’s pill version of Wegovy if it makes its US debut next year following potential ...

WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...

How Ozempic Is Changing Thanksgiving According to the independent research and polling source KFF, one in eight Americans reported taking a GLP-1 receptor agonist ...

(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S.

WeightWatchers to sell oral form of Wegovy if it launches next year; Dr. Richard Pazdur to head FDA’s CDER; anti-abortion group invests $80 million in campaign for midterm elections.

The comedian shared snaps of herself rocking a red strapless mini dress and a pair of black slingback heels via Instagram.